TuumIO Welcomes New Client for Global Phase 2 Clinical Trial

[BettyO]

We are excited to announce that a new clinical trial site has become a client of Care.Trials, TuumIO’s DeSci platform for clinical research. This trial site will utilize SOLVE tokens to find and enroll participants in a global Phase 2 clinical trial. By using the TuumIO Wallet, the site can manage patient recruitment more efficiently, solving one of the biggest hurdles in clinical trials: enrollment. 

Why This is Important 

Clinical trials are traditionally expensive, particularly when it comes to patient enrollment. On average, it costs between $10,000 and $40,000 to enroll a single participant. This prohibitive cost makes recruitment one of the biggest challenges for research teams. However, with Care.Trials, this site can significantly reduce these expenses—enrolling participants for less than 1% of the traditional cost. This not only makes the process more affordable but also opens the door to enrolling more patients globally. 

The Best Features of Care.Trials 

1. Easy to Use: 
   Care.Trials is designed with simplicity in mind, ensuring that both trial sites and participants can easily navigate the platform. From enrolling patients to managing trials, the process is smooth and intuitive. 

2. Zero-Knowledge Technology: 
   Privacy is at the core of Care.Trials. By utilizing zero-knowledge proofs, the platform ensures that sensitive patient data remains completely secure. Patient and provider information is handled privately, making it a safe and trustworthy solution for clinical trials. 

3. Accelerating Medicine and Science: 
   Care.Trials is helping speed up the research and development of new treatments. By decentralizing the trial process and making it easier for sites to enroll participants, we are driving faster innovation in medicine and science. 

We Are Bringing Web2 to Web3 

Care.Trials bridges the ease of Web2 with the innovation of Web3. By simplifying complex processes like clinical trial enrollment, it ensures that both patients and clinical sites can seamlessly interact with decentralized technologies—without needing deep crypto knowledge. With SOLVE tokens powering patient enrollment and rewards, we provide the simplicity and global reach of Web2 while leveraging the security and transparency of Web3. 

TuumIO is making it easier than ever for traditional systems to transition to decentralized science, ensuring that clinical trials benefit from the best of both worlds. 

SOLVE Token Adoption 

The use of Care.Trials by this clinic highlights the growing real-world utility of SOLVE tokens. As Care.Trials powers the patient enrollment process, SOLVE will be used to manage and reward participation, fueling decentralized solutions in healthcare. Care.Trials has projected the use of 565 million SOLVE tokens across clinical trial phases, marking this as a significant step in blockchain-driven healthcare. 

Looking Ahead 

This global Phase 2 clinical trial is a major validation of TuumIO’s vision for bringing Web2 into Web3. As the trial progresses, Care.Trials will continue to support future stages, driving even more demand for SOLVE tokens and expanding the reach of decentralized science. 

 Credit: TuumIO.com